ArticleFASEB bioAdvances2023

B cell-dependent subtypes and treatment-based immune correlates to survival in stage 3 and 4 lung adenocarcinomas.

Susan Raju Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.